Dallas, TX 10/8/2009 6:06:30 AM
News / Finance

Top NASDAQ Stocks – UCBH, SQNM, AVNR

UCBH, SQNM, AVNR – The Biggest Mover

Those investors who are planning to make money in the penny stock market should subscribe to FREE Alerts by visiting: http://www.PennyStockPickReport.com

 

UCBH Holdings, Inc. (NASDAQ:UCBH) was the top gainer of the day and rallied 6.03% or $0.07 to $1.23 on over 51.39 million shares after the reports from Bloomberg which said that  China Minsheng Banking Corp. is considering a plan to increase its stake in UCBH Holdings Inc.. The stock hit an intraday high of $1.49 and an intraday low of $1.18. UCBH Holdings, Inc. is a bank holding company. UCBH conducts its principal business through its wholly owned banking subsidiary, United Commercial Bank (UCB), which makes up substantially all of its consolidated assets and revenues. UCB is a California state-chartered commercial bank.


Sequenom, Inc. (NASDAQ:SQNM) spiked 11.19% or $0.33 to $3.28 on huge volume of over 12.49 million shares as Briefing Trader is reporting that the spike is due to rumors that Sequenom might put itself up for sale. Sequenom is an extremely volatile stock that has traded from a low of $2.83 to a high of $25.99 during the past 52 weeks. Sequenom's market cap stands at $200.60 million. Sequenom, Inc. (Sequenom) is a diagnostic testing and genetics analysis company. The Company is focused on providing products, services, diagnostic testing, applications and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock and other areas of research.


AVANIR Pharmaceuticals (NASDAQ:AVNR) was among the most active gainers in trade today. The stock opened the days trade at $2.20 and has rallied 13.62% to $2.42 on over 7.15 million shares after the company announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) announcing that it intends to grant the Company a new patent, extending the period of commercial exclusivity for its lead drug candidate Zenvia well into 2025. The stock gained more than 384% in past six months of trade. Avanir Pharmaceuticals is a pharmaceutical company focused on developing, acquiring and commercializing therapeutic products for the treatment of chronic diseases.


 

ABOUT PennyStockPickAlert.com

Penny Stock Pick Alerts by PennyStockPickAlert.com. We are a leading stock web site that provides free alerts on top penny stocks that are poised to make big gains. We also tracks small cap penny stocks that could be on the brink of a massive breakout